Tallantyre EC - Search Results

1

Real-world persistence of multiple sclerosis disease-modifying therapies.

Tallantyre EC, Dobson R, Froud JLJ, St John FA, Anderson VM, Arun T, Buckley L, Evangelou N, Ford HL, Galea I, George S, Gray OM, Hibbert AM, Hu M, Hughes SE, Ingram G, Kalra S, Lim CE, Mathews JTM, McDonnell GV, Mescall N, Norris S, Ramsay SJ, Rice CM, Russell MJ, Shawe-Taylor MJ, Williams TE, Harding KE, Robertson NP. Tallantyre EC, et al. Eur J Neurol. 2024 Jul;31(7):e16289. doi: 10.1111/ene.16289. Epub 2024 Apr 3. Eur J Neurol. 2024. PMID: 38567516 Free PMC article.

2

Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI.

Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Tallantyre EC, et al. Neurology. 2008 May 27;70(22):2076-8. doi: 10.1212/01.wnl.0000313377.49555.2e. Neurology. 2008. PMID: 18505982 No abstract available.

3

Spotlight on teriflunomide.

Tallantyre E, Evangelou N, Constantinescu CS. Tallantyre E, et al. Int MS J. 2008 Jun;15(2):62-8. Int MS J. 2008. PMID: 18782502 Review.

4

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.

Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N. Tallantyre EC, et al. Brain. 2009 May;132(Pt 5):1190-9. doi: 10.1093/brain/awp106. Brain. 2009. PMID: 19420101

5

A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG. Tallantyre EC, et al. Invest Radiol. 2009 Sep;44(9):491-4. doi: 10.1097/RLI.0b013e3181b4c144. Invest Radiol. 2009. PMID: 19652606

6

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis.

Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe JS, Evangelou N. Tallantyre EC, et al. Mult Scler. 2010 Apr;16(4):406-11. doi: 10.1177/1352458510364992. Epub 2010 Mar 9. Mult Scler. 2010. PMID: 20215480

7

3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, Evangelou N. Tallantyre EC, et al. J Magn Reson Imaging. 2010 Oct;32(4):971-7. doi: 10.1002/jmri.22115. J Magn Reson Imaging. 2010. PMID: 20882628

8

Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.

Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, Evangelou N. Tallantyre EC, et al. Neurology. 2011 Feb 8;76(6):534-9. doi: 10.1212/WNL.0b013e31820b7630. Neurology. 2011. PMID: 21300968 Free PMC article.

9

Focal multiple sclerosis lesions abound in 'normal appearing white matter'.

Mistry N, Tallantyre EC, Dixon JE, Galazis N, Jaspan T, Morgan PS, Morris P, Evangelou N. Mistry N, et al. Among authors: tallantyre ec. Mult Scler. 2011 Nov;17(11):1313-23. doi: 10.1177/1352458511415305. Epub 2011 Jul 25. Mult Scler. 2011. PMID: 21788249

10

Autism and intellectual disability.

Tallantyre E, Robertson NP. Tallantyre E, et al. J Neurol. 2013 Mar;260(3):936-9. doi: 10.1007/s00415-013-6861-y. J Neurol. 2013. PMID: 23423245 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters